ARID1A and hyperplasia: A literature review summarized these findings and indicated that high risk of cancer development was attributable to elevated estrogen concentrations leading to cystic malignant hyperplasia and/or ARID1A gene (SWI/SNF family member) mutations and, consequently, loss of BAF250a expression.